Compugen is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive AI/ML powered computational discovery platform (Unigen™) to identify new drug targets and biological pathways for developing cancer immunotherapies. Compugen has two proprietary product candidates in Phase 1 development: COM701, a potential first-in-class anti-PVRIG antibody and COM902, a potential best-in-class antibody targeting TIGIT for the treatment of solid tumors. Rilvegostomig, a PD-1/TIGIT bispecific antibody where the TIGIT component is derived from Compugen’s clinical stage anti-TIGIT antibody, COM902, is in Phase 3 development by AstraZeneca through a license agreement for the development of bispecific and multispecific antibodies. GS-0321 (previously COM503), a potential first-in-class, high affinity anti-IL-18 binding protein antibody, which is in Phase 1 development is licensed to Gilead. In addition, the Company’s therapeutic pipeline of early-stage immuno-oncology programs consists of research programs aiming to address new mechanisms to activate the immune system against cancer. Compugen is headquartered in Israel, with offices in San Francisco, CA. Compugen’s shares are listed on Nasdaq and the Tel Aviv Stock Exchange under the ticker symbol CGEN.
Company Details
- Employees
- 110
- Address
- Tel Aviv, Israel, Il
- Phone
- +972 3-765-8585
- jo****@****gen.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cgen.com
- Keywords
- Artificial Intelligence, Machine Learning, Immuno-oncology, Computational Biology, Clinical Development, Drug target discovery.
- HQ
- Tel Aviv, Israel
Compugen Questions
Compugen's helpline number is +972 3-765-8585
Compugen's website is http://www.cgen.com
Compugen's LinkedIn profile is https://www.linkedin.com/company/compugen-ltd
Compugen has
110 employees.
View email and phone details for 110
employees at Compugen.
Compugen's industry is
Biotechnology Research
Compugen's top competitors are
Immunai,
Biolojic Design, Ltd.,
Memed,
Protai,
Biomx (Nyse: Phge),
Evogene,
Compugen Inc,
Converge Bio,
Cytoreason,
Aion Labs.
Compugen's support email address is jobs@cgen.com
Compugen's categories are Biotechnology Research
